Clinical trials: Blood Purification
Immune Tolerance
Kidney and Blood Stem Cell Transplantation That Eliminates Requirement for Immunosuppressive Drugs
The Stanford Medical Center Program in Multi-Organ Transplantation and the Division of Bone Marrow Transplantation are enrolling patients into a research study to determine if blood stem cells injected after kidney…
- Trial name
- NCT00319657
- Testing
- Hematopoietic cell transplantation, Total lymphoid irradiation
- Where
- United States
- Volunteers
- 15 people
- Sponsor
- Stanford University
Hemophilia B
IMMUNINE Pre-Treatment Study
The primary objective of this study is to prospectively document the exposure to IMMUNINE and to monitor FIX inhibitors over a period of approximately 20 to 50 exposure days while receiving prophylactic treatment in up to 50…
- Trial name
- NCT01128881
- Testing
- Factor IX Concentrate (purified, virus-inactivated)
- Where
- 18 sites in Argentina, Brazil and 8 more
- Volunteers
- 57 people
- Sponsor
- Baxalta now part of Shire
Sepsis, Children, Only
Clinical Features and Outcomes of CBP Versus Non-CBP in Septic Children
The effect of continuous blood purification (CBP) in children is unclear. Also, the timing of early application is still being explored.
- Trial name
- NCT04794595
- Testing
- CBP
- Where
- China
- Volunteers
- 90 people
- Sponsor
- Children's Hospital of Fudan University
Covid19
Blood Purification With Seraph 100 Microbind Affinity Blood Filter for Treatment of Severe COVID19 Observational Study
This is a multi-center, observational study that will enroll 1) patients with severe COVID-19 who have agreed to undergo therapy with Seraph® 100 under the existing EUA; 2) patients (medical record data) that have been previously…
- Trial name
- PURIFY-OBS-1 (NCT04606498)
- Testing
- Observational
- Where
- 14 sites in United States
- Volunteers
- 200 people
- Sponsor
- Henry M. Jackson Foundation for the Advancement of Military Medicine